Cavanaugh Group, Inc.’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35.7K Buy
+575
New +$36.3K 0.01% 78

Other funds holding BMY

Cavanaugh Group, Inc.'s BMY Position: Q3 2026 in Review

Cavanaugh Group, Inc. opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 575 shares worth $35.7K. The stake represents 0.01% of the portfolio and ranks #78 among its holdings.

2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Cavanaugh Group, Inc. held 575 shares of Bristol-Myers Squibb worth $35.7K as of Q3 2026.
  • Bristol-Myers Squibb was a new Cavanaugh Group, Inc. position in Q3 2026.
  • Bristol-Myers Squibb made up 0.01% of Cavanaugh Group, Inc.'s portfolio in Q3 2026, its #78 holding.
  • 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Cavanaugh Group, Inc.'s 13F filing for Q3 2026, filed 17 Nov 2026.